Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk.

Front Endocrinol (Lausanne) · 2025 · PMC12286810 · PMID 40708721

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the ORION clinical trials, both single- and double-dose groups of Inclisiran showed a decrease in Lp(a) levels, although the reduction did not reach statistical significance, likely due to individual variability.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.